Antigen-specific cytokine responses in vaccinated Macaca nemestrina

T Mulvania1, J B Lynch, M N Robertson

  • 1Department of Microbiology, University of Washington, Seattle, USA. mulvania@u.washington.edu

Insights

A novel assay distinguishes cytotoxic T lymphocyte (CTL) activity from suppressive cytokines. This HIV-2 vaccine study in macaques revealed that robust CTL responses correlate with protective T-helper type 1 activity.

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • CD8+ T lymphocyte activity is crucial for controlling viral infections.
  • Distinguishing cytotoxic T lymphocyte (CTL) activity from cytokine-mediated suppression is challenging.
  • Human immunodeficiency virus type 2 (HIV-2) infection models are used to study vaccine efficacy.

Purpose of the Study:

  • To develop and apply a new surrogate assay for measuring CD8+ T lymphocyte activity.
  • To differentiate between CTL-mediated cytotoxicity and cytokine-driven suppression.
  • To evaluate the immune response in macaques vaccinated with an attenuated HIV-2 strain.

Main Methods:

  • Development of a novel surrogate assay for CD8+ T lymphocyte activity.
  • Application of the assay to two groups of Macaca nemestrina vaccinated with HIV-2(KR).
  • Group 1 received an additional inoculation with non-infectious HIV-2287, followed by challenge with infectious HIV-2287 for both groups.

Main Results:

  • Five of six animals in Group 1 were protected against CD4 decline, compared to three of six in Group 2.
  • Strong CTL responses against HIV-2(KR)-Gag were observed in Group 1.
  • Antigen-specific T-helper (Th) type 1 responses correlated with strong CTL responses.

Conclusions:

  • The new assay effectively distinguishes CTL activity from suppressive cytokine activity.
  • Vaccination with an attenuated HIV-2 strain, followed by exposure to a pathogenic strain, elicits protective immune responses.
  • Antigen-specific cytokine profiles, particularly Th1 responses, are associated with CD8+ T-cell-mediated protection against HIV-2.